Dominari Financial Granted Approval to Acquire Broker Dealer
Dominari Financial Granted Approval to Acquire Broker Dealer
PR Newswire
NEW YORK, March 21, 2023
NEW YORK, March 21, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today reported that on March 20, 2023, pursuant to FINRA Rule 1017, FINRA has approved the proposed change in ownership whereby its subsidiary Dominari Financial Inc. will become the sole owner of Fieldpoint Private Securities LLC. This matter is the next step in the previously announced agreement to buy Fieldpoint Private Securities. Final acquisition of the broker dealer is subject to a final closing, which by agreement among the parties, should occur within five (5) business days of FINRA approval.
About Dominari Holdings Inc.
Dominari Holdings Inc. (f/k/a Aikido Pharma Inc.) until recently was focused primarily on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. In September 2022, the Company agreed to acquire a registered broker-dealer and transition its primary business operations to fintech and financial services. Upon the final closing of this acquisition, the Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. The Company continues to develop its therapeutics and related patent technology, as well as other ventures, through its subsidiary, Aikido Labs, LLC.
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, which include but are not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
Contact:
Investor Relations:
Hayden IR
Brett Maas, Managing Partner
Phone: (646) 536-7331
Email: [email protected]
www.haydenir.com
Dominari Holdings Inc. (f/k/a AIkido Pharma Inc):
Phone: 212-745-1373
Email: [email protected]
www.aikidopharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/dominari-financial-granted-approval-to-acquire-broker-dealer-301777885.html
SOURCE Dominari Holdings Inc.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.